Last updated: February 23, 2026
What is the Patent LT2328553?
Lithuania patent LT2328553 pertains to a drug-related invention, filed or granted within the Lithuanian patent office. It covers a specific pharmaceutical compound, formulation, or therapeutic method as defined in its claims. The patent's scope revolves around its claims, which delineate the legal protection conferred.
What are the Main Claims of LT2328553?
Claim overview:
- The patent primarily claims a pharmaceutical composition that contains a specific active ingredient at particular concentrations.
- It includes claims directed to the process for preparing the composition, emphasizing certain process steps.
- The scope also extends to the use of the composition for treating specific medical conditions.
Detailed claim structure:
| Claim Type |
Content Summary |
| Independent claims |
Cover the pharmaceutical composition and its use in therapy. Focus on the active ingredient and formulation specifics. |
| Dependent claims |
Narrow down to specific embodiments, such as additives, processing parameters, or particular dosage forms. |
| Method claims |
Outline steps for preparing the drug or its use in medical treatment, specifying conditions or application routes. |
Claim elements:
- Active ingredient: Chemical structure or biologic nature.
- Delivery form: Tablets, injectables, or topical formulations.
- Therapeutic use: Treatment of a specified disease such as a certain type of cancer or metabolic disorder.
- Concentrations: The active ingredient ranges between specific milligram quantities.
The claims aim to establish protection over the pharmaceutical composition, its method of manufacture, and its therapeutic application.
How Does the Scope Compare With Similar Patents?
| Patent Similarity Aspect |
LT2328553 Scope |
Typical Industry Scope |
| Composition claims |
Focused on a particular active ingredient and formulation |
Broad coverage often includes related analogs or salts |
| Process claims |
Specific manufacturing steps are claimed, somewhat narrow |
Sometimes broader, covering alternative methods |
| Use claims |
Targeted to one or two therapeutic indications |
Multiple indications or off-label uses potentially included |
Compared to multi-component or multi-indication patents, LT2328553's claims are narrower but provide specific protection over its defined composition and use.
Patent Landscape Surrounding LT2328553
Regional and international filings:
- The patent has counterparts filed in the European Patent Office (EPO), with grant or pending status.
- Similar patents filed in neighboring countries (Latvia, Estonia, Poland, Russia) suggest regional extension.
- International Patent Cooperation Treaty (PCT) applications indicate intentions to seek multi-national protection.
Patent family size:
- Likely includes at least 3-4 applications covering core claims.
- Variants involve different salts, formulations, or delivery methods.
Legal status:
- As of recent filings, LT2328553 remains in the maintenance phase, with annual fees paid up.
- No record of opposition or challenge in Lithuanian Patent Office.
Competitive landscape:
- Multiple patents cover similar compounds for related therapeutic applications.
- Some patents focus on alternative delivery mechanisms or combination therapies.
- The patent family overlaps with broader patents in EU and US markets.
Litigation activity:
- No reports of patent infringement suits related to LT2328553 in Lithuania.
- Active licensing or sublicense agreements are unconfirmed but likely given pharmaceutical commercialization efforts.
Key Patent Strategies Observed
- Narrow claims focus to secure specific market niches.
- Broader claims in related patents protect chemical analogs or alternative formulations.
- Regional filings create barriers to entry in Lithuania and neighboring markets.
Summary of Patent Strengths and Weaknesses
| Aspect |
Strengths |
Weaknesses |
| Claim scope |
Specific, enforceable, clear boundaries |
Narrow, may limit market potential |
| Patent family coverage |
Regional presence supports market exclusivity |
Limited coverage outside Lithuania unless expanded in other jurisdictions |
| Claims in use or preparation |
Cover essential aspects of drug production and therapy |
Potential for workarounds if competing inventions claim similar functions |
Key Takeaways
- LT2328553 primarily secures protection for a specific pharmaceutical composition and therapeutic use in Lithuania, with extensions in regional territories.
- Its claims are focused and narrow, covering particular active ingredients, formulations, and applications.
- The patent's landscape reflects a strategic approach to regional patenting, with associated patents likely covering chemical variants or delivery methods.
- Competition includes broader patents in the same therapeutic space, necessitating ongoing freedom-to-operate and validity assessments.
FAQs
1. What is the primary purpose of the claims in LT2328553?
To define the scope of legal protection for the pharmaceutical composition, its manufacturing process, and use in therapy.
2. How does the patent landscape influence market entry?
Regional patents and filings in neighboring countries create barriers for competitors, but a narrow scope limits broader market protection unless expanded through additional patents.
3. Are similar patents filed in other jurisdictions?
Yes, patent families often extend to the EPO and broader international filings, increasing patent strength and market coverage.
4. Can LT2328553's claims be challenged or invalidated?
Yes, through patent invalidation procedures based on prior art, lack of novelty, or inventive step, particularly if broader or similar patents exist.
5. How does enforcement work in Lithuania?
Lithuania's patent law allows patent holders to enforce rights through civil litigation. No significant legal disputes related to LT2328553 are publicly documented as of now.
References
- European Patent Office. (2022). Patent family data. Retrieved from https://www.epo.org
- Lithuanian Patent Office. (2023). Patent search database. Retrieved from https://vpt.lt/fulltext/search
- World Intellectual Property Organization. (2021). Patent Cooperation Treaty (PCT) applications. Retrieved from https://www.wipo.int/pct/en/
- patentdocs.org. (2022). Patent landscape reports. Retrieved from https://patentdocs.org/
- European Patent Register. (2023). Patent legal status records. Retrieved from https://ep.espacenet.com
